An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined with Obinutuzumab Compared with Obinutuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma

Project: Research

Project Details

StatusActive
Effective start/end date28/05/20 → 27/05/25

Keywords

  • clinical trial
  • phase 2 study
  • Lymphoma
  • treatment efficacy
  • treatment safety